Amneal Pharmaceuticals Inc (AMRX)
5.40
+0.03
(+0.56%)
USD |
NASDAQ |
Apr 23, 16:00
5.99
+0.59
(+10.93%)
Pre-Market: 09:20
Amneal Pharmaceuticals Price: 5.40 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 5.41 | 5.48 | 5.355 | 5.40 | 1.381M |
| Apr 22, 2024 | 5.41 | 5.43 | 5.18 | 5.37 | 1.848M |
| Apr 19, 2024 | 5.33 | 5.43 | 5.33 | 5.42 | 1.058M |
| Apr 18, 2024 | 5.46 | 5.47 | 5.34 | 5.36 | 843286.0 |
| Apr 17, 2024 | 5.52 | 5.52 | 5.37 | 5.46 | 1.220M |
| Apr 16, 2024 | 5.48 | 5.54 | 5.38 | 5.45 | 1.204M |
| Apr 15, 2024 | 5.50 | 5.67 | 5.47 | 5.54 | 1.118M |
| Apr 12, 2024 | 5.68 | 5.81 | 5.42 | 5.52 | 2.185M |
| Apr 11, 2024 | 5.72 | 5.81 | 5.65 | 5.69 | 1.275M |
| Apr 10, 2024 | 5.70 | 5.92 | 5.61 | 5.70 | 1.777M |
| Apr 09, 2024 | 6.00 | 6.03 | 5.72 | 5.73 | 2.314M |
| Apr 08, 2024 | 6.16 | 6.330 | 5.96 | 6.00 | 1.377M |
| Apr 05, 2024 | 5.95 | 6.195 | 5.925 | 6.12 | 1.991M |
| Apr 04, 2024 | 6.10 | 6.21 | 5.94 | 5.96 | 1.231M |
| Apr 03, 2024 | 5.75 | 6.120 | 5.67 | 6.02 | 1.823M |
| Apr 02, 2024 | 5.99 | 6.00 | 5.78 | 5.81 | 1.221M |
| Apr 01, 2024 | 6.07 | 6.13 | 5.90 | 6.05 | 1.186M |
| Mar 28, 2024 | 6.14 | 6.21 | 5.97 | 6.06 | 2.884M |
| Mar 27, 2024 | 5.86 | 6.145 | 5.71 | 6.12 | 1.913M |
| Mar 26, 2024 | 5.98 | 6.00 | 5.81 | 5.85 | 1.896M |
| Mar 25, 2024 | 6.07 | 6.09 | 5.90 | 5.91 | 889275.0 |
| Mar 22, 2024 | 6.29 | 6.29 | 6.005 | 6.07 | 2.229M |
| Mar 21, 2024 | 6.32 | 6.33 | 6.19 | 6.29 | 1.030M |
| Mar 20, 2024 | 6.31 | 6.32 | 5.975 | 6.08 | 1.389M |
| Mar 19, 2024 | 5.90 | 6.46 | 5.785 | 6.34 | 3.212M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.27
Minimum
Mar 28 2023
14.05
Maximum
May 06 2019
4.226
Average
4.22
Median
Aug 11 2020
Price Benchmarks
| Fate Therapeutics Inc | 4.54 |
| Ocular Therapeutix Inc | 5.00 |
| AnaptysBio Inc | 19.18 |
| Stoke Therapeutics Inc | 11.26 |
| Omega Therapeutics Inc | 2.34 |
Price Related Metrics
| PS Ratio | 0.4011 |
| Price to Book Value | 83.81 |
| Price to Free Cash Flow | 3.474 |
| Earnings Yield | -9.07% |
| Market Cap | 1.658B |
| Operating PE Ratio | 4.281 |